Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 1
2005 2
2006 3
2007 6
2008 2
2010 2
2012 1
2013 2
2014 3
2015 9
2016 1
2017 3
2018 2
2019 4
2020 4
2021 5
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
Nakamura N, Kobashi Y, Kim KS, Park H, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Yoshida M, Abe T, Saito Y, Senoo Y, Nonaka S, Takita M, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Jeong YD, Tatematsu D, Akao M, Sato Y, Iwanami S, Fujita Y, Wakui M, Aihara K, Kodama T, Shibuya K, Iwami S, Tsubokura M. Nakamura N, et al. Among authors: sugiyama a. PLOS Digit Health. 2024 May 3;3(5):e0000497. doi: 10.1371/journal.pdig.0000497. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38701055
Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin.
Sakata J, Tatsumi T, Sugiyama A, Shimizu A, Inagaki Y, Katoh H, Yamashita T, Takahashi K, Aki S, Kaneko Y, Kawamura T, Miura M, Ishii M, Osawa T, Tanaka T, Ishikawa S, Tsukagoshi M, Chansler M, Kodama T, Kanai M, Tokuyama H, Yamatsugu K. Sakata J, et al. Among authors: sugiyama a. Protein Expr Purif. 2024 Feb;214:106375. doi: 10.1016/j.pep.2023.106375. Epub 2023 Oct 4. Protein Expr Purif. 2024. PMID: 37797818 Free article.
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Tani Y, et al. Among authors: sugiyama a. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. Front Immunol. 2023. PMID: 37662950 Free PMC article.
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
Tani Y, Takita M, Kobashi Y, Wakui M, Zhao T, Yamamoto C, Saito H, Kawashima M, Sugiura S, Nishikawa Y, Omata F, Shimazu Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Kami M, Tsubokura M. Tani Y, et al. Among authors: sugiyama a. Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920. Vaccines (Basel). 2023. PMID: 37243024 Free PMC article.
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study.
Kawashima M, Saito H, Nishiuchi T, Yoshimura H, Wakui M, Tani Y, Nishikawa Y, Omata F, Takita M, Zhao T, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Sawano T, Shibuya K, Kazama J, Shineha R, Tsubokura M. Kawashima M, et al. Among authors: sugiyama a. Vaccines (Basel). 2023 Jan 25;11(2):260. doi: 10.3390/vaccines11020260. Vaccines (Basel). 2023. PMID: 36851137 Free PMC article.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Kobashi Y, Kawamura T, Shimazu Y, Zhao T, Sugiyama A, Nakayama A, Kaneko Y, Nishikawa Y, Omata F, Takita M, Yamamoto C, Yoshida M, Kosaka M, Murayama A, Sugiura S, Tanaka M, Kawashima M, Uchi Y, Shindo J, Oikawa T, Shibuya K, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: sugiyama a. Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x. Sci Rep. 2022. PMID: 36344597 Free PMC article.
Nucleic acid-triggered tumoral immunity propagates pH-selective therapeutic antibodies through tumor-driven epitope spreading.
Furuya G, Katoh H, Atsumi S, Hashimoto I, Komura D, Hatanaka R, Senga S, Hayashi S, Akita S, Matsumura H, Miura A, Mita H, Nakakido M, Nagatoishi S, Sugiyama A, Suzuki R, Konishi H, Yamamoto A, Abe H, Hiraoka N, Aoki K, Kato Y, Seto Y, Yoshimura C, Miyadera K, Tsumoto K, Ushiku T, Ishikawa S. Furuya G, et al. Among authors: sugiyama a. Cancer Sci. 2023 Jan;114(1):321-338. doi: 10.1111/cas.15596. Epub 2022 Oct 17. Cancer Sci. 2023. PMID: 36136061 Free PMC article.
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.
Kaneko Y, Yamatsugu K, Yamashita T, Takahashi K, Tanaka T, Aki S, Tatsumi T, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Tsukagoshi M, Chansler M, Sugiyama A, Kanai M, Katoh H. Kaneko Y, et al. Among authors: sugiyama a. Cancer Sci. 2022 Dec;113(12):4350-4362. doi: 10.1111/cas.15565. Epub 2022 Sep 19. Cancer Sci. 2022. PMID: 36121618 Free PMC article.
The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan.
Kaneko Y, Sugiyama A, Tanaka T, Fukui K, Taguchi A, Tatsuno K, Nakayama A, Koga K, Kishi Y, Daming W, Qian C, Xia F, He F, Zheng L, Yu Y, Wada Y, Wada Y, Kodama T, Kawamura T. Kaneko Y, et al. Among authors: sugiyama a. Health Sci Rep. 2022 Apr 13;5(3):e572. doi: 10.1002/hsr2.572. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35509410 Free PMC article.
62 results